A Study in Adults With Geographic Atrophy

Summary

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part of the eye slowly die, causing a blurry, or missing spot in the centre of vision.

Timeline

Start

2026-06

Primary completion

2028-07

Completion

2029-08

Drugs

Indications